Skip to main content

Clinical Decision Support System (CDSS) Market Applications Scope and Rising Demand Analysis

Clinical decision support systems are versatile, which has spurred adoption among healthcare organizations. The rise in the number of hospitals, surging cases of medical emergency, and the rise in geriatric population are key factors boosting the growth of the market.
Market Overview
Clinical Decision Support Systems are computerized systems, which are designed to provide deep-diving insights to healthcare professionals to aid in numerous decision-making activities. Such systems include a variable cast of devices and vary according to the nature of the diseases being treated. In recent years, clinical decision support systems have become a valuable guidance tool for the healthcare industry.
The Clinical Decision Support System (CDSS) Market, as per Market Research Future (MRFR), in its latest report, is likely to expand at CAGR of 12% to reach a valuation of USD 1.76 Bn by the end of the assessment period of 2018-2023.
However, such systems run the risk of data breach, which can be disruptive to the growth of the market. Meanwhile, the market is likely to benefit from the shift of the healthcare sector towards data-driven technologies, and the advent of healthcare technologies such as healthcare AI, EMRs, and other healthcare technologies.
Competitive Landscape
Product launches and investment in R&D are a few of the important strategies employed by the top players in the global market to facilitate growth.
Hearst Health, Allscripts, Agfa-Gevaert Group, Wolters Kluwer Health, Athenahealth, Inc, Elsevier B.V., Meditech, Cerner Corporation, Epic Systems Corporation, and Carestream are the key players in the clinical decision support system market.
Segmentation
The global clinical decision support systems market has been segmented based on component, product type, model, delivery mode, mode of advice, setting, type, and application.
By component, the clinical decision support systems market has been segmented into software, hardware, and services. The software segment held the largest share of the market and stood at USD 493.43 Mn in 2017. The software segment is anticipated to reach USD 982.42 Mn by the end of 2023.
By product, the clinical decision support systems market has been segmented into integrated and standalone variants. The integrated CDSS segment accounts for the larger share of the global market and is anticipated to capture the highest CAGR as well. Integrated CDSS allows healthcare professionals to share a common interface and database, thus, simplifying processes.
By model, the clinical decision support systems market has been segmented into knowledge-based and non-knowledge-based CDSS. The knowledge-based CDSS segment has the upper hand in the market. These systems aid in decision making in uncertain conditions and are easy to access.
By delivery mode, the clinical decision support systems market has been segmented into cloud and on-premise.
By mode of advice, the clinical decision support systems market has been segmented into active and passive. With almost 75% share of the market, the active CDSS segment is domineering the global market.
By setting, the clinical decision support systems market has been segmented into inpatient settings and ambulatory care. The inpatient setting segment accounts for the majority share of 70% of the global market.
By type, the clinical decision support systems market has been segmented into therapeutic and diagnostic CDSS.
By application, the clinical decision support systems market has been segmented into advanced and conventional CDSS.
Intended Audience
  • Medical Devices Companies
  • Research and Development (R&D) Companies
  • Government Research Institutes
  • Academic Institutes and Universities
Browse the market data and in-depth information of this Report at: https://www.marketresearchfuture.com/reports/clinical-decision-support-systems-market-6038
Regional Analysis
Region-wise, the clinical decision support market has been segmented into North America, Asia Pacific (APAC), the Middle East & Africa (MEA), Latin America, and Europe.
North America holds the largest share of the global clinical decision support systems market. The existence of major key players in the region gives leverage over others. Moreover, the advanced state of healthcare in the region and high expenditure on healthcare are furthering the growth of the market.
Europe accounts for an advantageous share of the global market and is likely to exhibit rapid growth over the forecast period. Government initiative undertaken to improve the healthcare sector, accessibility of advanced healthcare facilities, and increasing healthcare expenditure is some of the factors driving the growth of the Europe market.
Relentless strides made by the government of the emerging economies of APAC towards the modernization of the healthcare sector is likely to fuel the growth of the APAC market.
Market Growth Factor Analysis
5.1 Porter’s Five Forces Analysis
5.1.1 Bargaining Power Of Suppliers
5.1.2 Bargaining Power Of Buyers
5.1.3 Threat Of New Entrants
5.1.4 Threat Of Substitutes
5.1.5 Intensity Of Rivalry
5.2 Investment Opportunity Analysis
5.3 Value Chain Analysis
5.3.1 Inputs
…To be Continued
About Market Research Future:
Our team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by products, services, technologies, applications, end users, and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.
In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.
Contact:
Market Research Future
Phone: +16468459312

Comments

Post a Comment

Popular posts from this blog

U.S. Uterine Fibroid Market Latest Devices, Key Players Statistics Data, Regional Business Outlook 2022

U.S. Uterine Fibroid Market by Type (Subserosal Fibroids, Intramural Fibroids, Submucosal Fibroids and others), by Diagnosis (Medical Resonance Imaging (MRI) scanners, Computed Tomography (CT), Ultrasounds and others) and Treatment (Uterine Fibroid Embolization, Magnetic Resonance Guided Focused Ultrasound, Myolysis, Endometrial Ablation, Hysterectomy and Myomectomy) - Forecast to 2022 The  US Uterine Fibroid Market  report offers insights into the leading market players and presents an assessment of their current market position. Company information with regards to revenue, segmental share, geographical income, SWOT, growth strategies, new product launch, M&A activities, and the latest R&D initiatives is also available in the report Major Key Players To gain a substantially large competitive advantage, these players incorporate strategic initiatives such as mergers & acquisitions, collaboration, expansion, and product launch. These are the Top Market...
Post a Comment
Read more

Hemifacial Spasm Market Application Scope, Types, Technology Benefits and Global Business

  Hemifacial Spasm Market  Research Information: By Diagnosis (Mri, Ct Or Cat Scan, Angiography (Arteriography)), Treatment (Medical Treatment, Surgical Treatment, Combinational Therapy, Tens, Physical Therapy, Others), End User – Global Forecast Till 2023 Market Highlights: Hemifacial spasm is a condition that causes frequent muscle spasms, on one side of the face. The condition can affect both men and women, but it is most prevalent in middle-aged or older women. Its incidence rate is also found to be higher among the Asian population. A number of factors such as increasing technological advancements, rising public awareness, increased incidence of craniofacial tremor, and facial chorea, unmet medical needs, increasing government assistance, improving regulatory framework, increasing adoption rate, and improvement in funding and reimbursement policies are propelling the growth of the global hemifacial spasm market. However, difficult diagnosis, cost of treatment, side-effect...
Post a Comment
Read more

LOW-E Glass Market Opportunities, Current Trends And Restraints Forecast 2026

IDA Provides LOW-E Glass Growth Analysis 2021 Report by Key Players, Types, Applications, Countries, and Forecast. The Final Research Insights will get the complete Pandemic Impact Analysis Till 2026 This LOW-E Glass Market research report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key players and the market as a whole. The global Industry growth depends on several factors that are Rising inclusion of artificial intelligence, automation, internet of things and others are expected to make sure that the market gains good mileage. Involving demand estimation, new product development and entry strategies, marketing and distribution strategies in the high-risk arena of new developments by helping you identify unmet needs. The LOW-E Glass Market Major Eminent players making significant moves in the global market have earned their reputation by launching various strategies and profiting: Saint-gobain, NSG, PPG, AGC, Guardia...
Post a Comment
Read more